Cite
Cabozantinib inhibits tumor growth and metastasis of a patient-derived xenograft model of papillary renal cell carcinoma with MET mutation.
MLA
Zhao, Hongjuan, et al. “Cabozantinib Inhibits Tumor Growth and Metastasis of a Patient-Derived Xenograft Model of Papillary Renal Cell Carcinoma with MET Mutation.” Cancer Biology & Therapy, vol. 18, no. 11, Nov. 2017, pp. 863–71. EBSCOhost, https://doi.org/10.1080/15384047.2016.1219816.
APA
Zhao, H., Nolley, R., Chan, A. M. W., Rankin, E. B., & Peehl, D. M. (2017). Cabozantinib inhibits tumor growth and metastasis of a patient-derived xenograft model of papillary renal cell carcinoma with MET mutation. Cancer Biology & Therapy, 18(11), 863–871. https://doi.org/10.1080/15384047.2016.1219816
Chicago
Zhao, Hongjuan, Rosalie Nolley, Andy M. W. Chan, Erinn B. Rankin, and Donna M. Peehl. 2017. “Cabozantinib Inhibits Tumor Growth and Metastasis of a Patient-Derived Xenograft Model of Papillary Renal Cell Carcinoma with MET Mutation.” Cancer Biology & Therapy 18 (11): 863–71. doi:10.1080/15384047.2016.1219816.